NCT03826433View on ClinicalTrials.gov

hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis

PHASE1RecruitingINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

October 1, 2018

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2025

Conditions

Hepatitis B

Interventions

BIOLOGICAL

Peripheral iv

6\*10\^7 cells

Trial Locations (1)

410008

RECRUITING

Xiangya Hospital Central South University, Changsha

All Listed Sponsors

lead

Sclnow Biotechnology Co., Ltd.

INDUSTRY